Items tagged with Research and development
Global pharmaceutical industry calls on governments to work with them to beat the rising threat of antimicrobial resistance (post with simple image)
In a joint declaration more than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, call on governments and industry to work in parallel in taking comprehensive action against antimicrobial resistance.
UNITAID study looks at delinking cost of R&D from price of medicines (post with simple image)
The study explores how to separate the costs of research and development (R&D) from the future market price of vaccines, medicines and diagnostics – a concept known as “delinkage”.
UAEM calls for a people-centered approach to biomedical R&D (post with simple image)
Universities Allied for Essential Medicines (UAEM) launches Re:Route, a mapping of alternative biomedical research and development (R&D) initiatives.
Lives on the Edge: Time to align medical research and development with people’s health needs (post with simple image)
Médecins Sans Frontières (MSF) released a report that outlines shortcomings of the current system for new drug development. The report highlights resulting access barriers and proposes policy solutions.
Tackling drug-resistant infections globally: final report and recommendations (post with simple image)
The Review on Antimicrobial Resistance released its final report and recommendations warning that antimicrobial-resistant infections such as drug-resistant tuberculosis could kill 10 million people a year by 2050 without an urgent expansion of resources and funds.
The time is now: how we can start taking action on TB R&D (post with simple image)
Treatment Action Group released a new resource, Breathing Life into Flatlined U.S. Government Funding for Tuberculosis Research: FY 2017–2020 Allocations and Recommendation, to spark and support ongoing advocacy on TB R&D.
Mike Frick's plenary talk at TB2016 in Durban (post with simple image)
Mike Frick's plenary talk delivered at TB2016 Durban, South Africa, July 16, 2016.
As U.N. General Assembly starts, MSF urges governments to set medical research policies that align with people’s health needs (post with simple image)
New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs.
U.N. High-Level Panel on Access to Medicines releases final report (post with simple image)
United Nations Secretary-General’s High-Level Panel on Access to Medicines calls for new deal to close the health innovation and access gap.
Funding for TB research falls to lowest level in seven years (post with simple image)
Treatment Action Group’s Report on Tuberculosis Research Funding Trends, 2005–2015: No Time to Lose shows that the world spent US$620.6 million on TB research and development in 2015, the lowest level of funding since 2008.
Page 13 of 15 · Total posts: 0←First 12 13 14 Last→